Evidence map›Paper›PMID 29953871›Full record

ReviewNeuron2018

Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert.

Andreas Reiner, Joshua Levitz

Abstract readReview
In one paragraph

Review in Neuron, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 338 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
338citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

338 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Dynamic Metabolic Changes Driven by Exercise Intensity in Acute Swimming.Medicine and science in sports and exercise · 2025
    Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

278 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Andreas ReinerDepartment of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany. Electronic address: andreas.reiner@rub.de.
Joshua LevitzDepartment of Biochemistry, Weill Cornell Medicine, New York, NY, USA. Electronic address: jtl2003@med.cornell.edu.

Funding

Molecular Mechanisms of Synaptic G Protein-Coupled ReceptorsR35GM124731 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEVITZ, JOSHUA · 2017 to 2021
$2.1M
NIGMS NIH HHS R35 GM124731
6 · The paper itself

Abstract

Glutamate serves as both the mammalian brain's primary excitatory neurotransmitter and as a key neuromodulator to control synapse and circuit function over a wide range of spatial and temporal scales. This functional diversity is decoded by two receptor families: ionotropic glutamate receptors (iGluRs) and metabotropic glutamate receptors (mGluRs). The challenges posed by the complexity and physiological importance of each of these subtypes has limited our appreciation and understanding of how these receptors work in concert. In this review, by comparing both receptor families with a focus on their crosstalk, we argue for a more holistic understanding of neural glutamate signaling.

Indexed as

AnimalsBrainCentral Nervous SystemGlutamic AcidHumansNeuronal PlasticityNeurotransmitter AgentsOptogeneticsReceptors, Ionotropic GlutamateReceptors, Metabotropic GlutamateSynaptic TransmissionGlutamic AcidNeurotransmitter AgentsReceptors, Ionotropic GlutamateReceptors, Metabotropic Glutamateglutamate receptorG protein-coupled receptoriGluRion channelmGluRneuromodulationneurotransmitteroptogeneticsreceptor crosstalksynapsesynaptic plasticity

Identifiers

PMID29953871
PMCPMC6484838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.